(Q46197928)

20 December 2017

title

Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-hodgkin's lymphoma (English)

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

4 November 2022

1 reference

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

4 November 2022

3

L. Taylor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707337

4 November 2022

author name string

DeAngelis LM

1

1 reference

20 December 2017

Warrell RP Jr

4

1 reference

20 December 2017

L. M. DeAngelis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707337

4 November 2022

C. Gnecco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707337

4 November 2022

R. P. Warrell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707337

4 November 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

20 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

4 November 2022

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

4 November 2022

1 reference

20 December 2017

volume

67

1 reference

20 December 2017

issue

9

1 reference

20 December 2017

page(s)

2241-2246

1 reference

20 December 2017

Ganglioside therapy for amyotrophic lateral sclerosis: a double-blind controlled trial.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819910501%2967%3A9%3C2241%3A%3AAID-CNCR2820670905%3E3.0.CO%3B2-A

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy

21 January 2018

1

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

4 November 2022

2

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma

4 November 2022

4

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

4 November 2022

5

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience

4 November 2022

6

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

4 November 2022

7

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Twenty years of MOPP therapy for Hodgkin's disease

4 November 2022

9

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Single agent vincristine by infusion in refractory multiple myeloma

4 November 2022

10

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Intravenous vincristine infusion: Phase I trial

4 November 2022

12

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion

4 November 2022

13

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growth

4 November 2022

14

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Ganglioside stimulation of axonal sprouting in vitro

4 November 2022

15

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Muscle reinnervation--III. Motoneuron sprouting capacity, enhancement by exogenous gangliosides

4 November 2022

16

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Reduction of cerebral edema with GM1 ganglioside

4 November 2022

17

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

The functional recovery of damaged brain: The effect of GM1 monosialoganglioside

4 November 2022

18

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Ganglioside therapy in diabetic neuropathy

4 November 2022

19

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Ganglioside treatment of vincristine-induced neuropathy. An electrophysiologic study

4 November 2022

21

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Efficacy of ganglioside treatment in reducing functional alterations induced by vincristine in rabbit peripheral nerves

4 November 2022

22

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

4 November 2022

25

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Use of Ranks in One-Criterion Variance Analysis

4 November 2022

26

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis

4 November 2022

27

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Chemotherapy for advanced aggressive lymphoma: more is better ...isn't it?

4 November 2022

29

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD

4 November 2022

30

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Clinical trial of folinic acid to reduce vincristine neurotoxicity

4 November 2022

31

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Clinical trial of pyridoxine to reduce vincristine neurotoxicity

4 November 2022

32

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Amelioration of vincristine neurotoxicity by glutamic acid

4 November 2022

33

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

4 November 2022

34

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons

4 November 2022

35

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

Vincristine neuropathy. Clinical and electrophysiological observations

4 November 2022

36

1 reference

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(19910501)67:9%3C2241::AID-CNCR2820670905%3E3.0.CO;2-A

4 November 2022

Identifiers

10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A

1 reference

20 December 2017

1 reference

20 December 2017